Dermatologic Adverse Events Associated With Afatinib: An Oral ErbB Family Blocker

    Mario E. Lacouture, Dirk Schadendorf, Chia‐Yu Chu, Sung‐Bae Kim, Uz Stammberger, Dennis O’Brien, Axel Hauschild
    Studysummary This article summarizes dermatologic adverse events in patients treated with afatinib in clinical trials and discusses strategies for managing these side effects, without providing new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results